Plaquenil (hydroxychloroquine) helps lupus by calming an overactive immune system that mistakenly attacks the body’s own tissues. It does this primarily by changing conditions inside immune cells so they can’t mount as strong an inflammatory response. The drug is considered so effective that the European Alliance of Associations for Rheumatology recommends it for all patients with systemic lupus erythematosus, regardless of disease severity. Most people start noticing improvements within one to two months, though full benefits can take up to six months.
How It Works Inside Your Immune Cells
Hydroxychloroquine is a weak base, meaning it naturally accumulates in the acidic compartments of your cells called lysosomes. These tiny structures act like recycling centers, breaking down proteins and waste at a low pH (around 4.7 to 4.8). When hydroxychloroquine builds up inside them, it raises the pH to about 6, making the environment far less acidic. That shift disrupts the lysosomes’ ability to do their job properly.
This matters for lupus because lysosomes play a key role in how immune cells identify threats. In lupus, immune cells mistakenly present the body’s own proteins as foreign invaders. By raising lysosomal pH, hydroxychloroquine interferes with this faulty self-recognition process, reducing the immune system’s tendency to attack healthy tissue.
The drug also dials down inflammation through several other pathways. It suppresses the production of inflammatory signaling molecules, including ones involved in fever, tissue swelling, and immune cell recruitment. It limits the proliferation of both T cells and B cells, the two main types of immune cells driving lupus activity. And it promotes the development of regulatory T cells, a specialized subset that acts as a brake on the immune response. The net effect is a broadly dampened inflammatory state without the level of immune suppression that comes with stronger drugs.
What Improves: Joints, Skin, and Flares
The most noticeable benefits for many people with lupus involve joint pain and skin rashes, two of the disease’s most common symptoms. Hydroxychloroquine reduces joint inflammation and has been shown to improve skin manifestations while lowering the need for corticosteroids to manage them. For people with stable, quiet disease, using hydroxychloroquine cuts the risk of a severe flare by 57%.
Stopping or even reducing the dose carries real consequences. A large study of 1,460 lupus patients found that those who reduced their hydroxychloroquine dose were 20% more likely to experience a flare compared to those who stayed on it. Those who stopped entirely were 56% more likely to flare. This is why rheumatologists generally encourage patients to continue the medication even when they feel well.
Protection Against Long-Term Organ Damage
Lupus can quietly damage organs over years, even between flares. A systematic review covering 25 years of published data found strong evidence that hydroxychloroquine increases long-term survival in lupus patients. The same body of research showed moderate evidence that the drug protects against irreversible organ damage, blood clot formation, and bone mass loss. These aren’t dramatic, fast-acting benefits you’d feel day to day, but they compound over years into meaningfully better health outcomes.
Cardiovascular and Blood Clot Benefits
People with lupus face an elevated risk of blood clots, especially those who carry antiphospholipid antibodies. Hydroxychloroquine blocks platelet aggregation and adhesion (the early steps that form clots) and improves cholesterol profiles. In one study of patients with antiphospholipid syndrome who were already on blood thinners, adding hydroxychloroquine dropped the three-year recurrence rate of blood clots from 30% to 0%. While that study was small (40 patients), it illustrates the drug’s anti-clotting potential on top of its anti-inflammatory effects.
Safety During Pregnancy
Hydroxychloroquine is one of the few lupus medications considered safe to take during pregnancy, and in certain cases, it provides direct protection for the baby. Mothers with specific antibodies called anti-SSA/Ro face an 18% risk that their baby will develop congenital heart block, a serious condition where the heart’s electrical signals are disrupted. In a prospective study published in the Journal of the American College of Cardiology, mothers who took hydroxychloroquine during pregnancy saw that recurrence rate drop to 5%, a reduction of more than 50%. The drug works by suppressing the same inflammatory pathway in the placenta that it targets elsewhere in the body.
The Main Risk: Retinal Toxicity
The most significant long-term concern with hydroxychloroquine is potential damage to the retina. The risk is low in the first five years of use but increases with longer duration and higher doses. To minimize this risk, the recommended daily dose is no more than 5 mg per kilogram of actual body weight, with an absolute ceiling of 400 mg per day for most people. Patients with severe obesity may need to start at a lower dose since dosing by weight alone could lead to too much medication.
Risk factors for retinal damage include daily doses that exceed these thresholds, more than five years of continuous use, kidney problems that slow drug clearance, and certain other medications taken at the same time. The American Academy of Ophthalmology recommends baseline eye exams and regular screening, typically with imaging that can detect very early retinal changes before vision is affected. When caught early, stopping the drug prevents further damage.
What to Expect When Starting
Hydroxychloroquine is not a fast-acting drug. You may notice some improvement in joint pain or skin symptoms within the first one to two months, but the full therapeutic effect builds gradually over six months. This slow onset is because the drug works by shifting the immune system’s baseline behavior rather than suppressing a single acute process. Many people take it alongside other lupus medications initially, then taper those as hydroxychloroquine reaches its full effect.
The drug is taken as a daily oral tablet. Common side effects are generally mild and include nausea, stomach cramps, and diarrhea, which often improve after the first few weeks. Compared to other lupus treatments like high-dose corticosteroids or stronger immunosuppressants, hydroxychloroquine has a favorable safety profile, which is a major reason it’s recommended as a cornerstone of lupus management for virtually every patient.